| LDL (“bad”) cholesterol: oat products | LDL was 0.27 mmol/L lower on average than in the control group (95% confidence interval for the reduction, 0.20–0.35 mmol/L). | 2/4 LowThe review included 13 trials covering different lipid outcomes. Twelve measured LDL, and one trial contributed two dose comparisons. Results varied considerably across products and studies (I² = 83.3%). The average reduction cannot be attributed to each individual supplement. This finding applies to adults with high cholesterol. It does not show how much LDL would fall in someone whose LDL is already in the normal range. | 11 publicationEffects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | Adults with high cholesterol, with 12 trials and 13 dose comparisons for LDL | - Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| LDL (“bad”) cholesterol: beta-glucan tablets | LDL did not decrease compared with placebo. Changes at 1.5, 3, and 6 g per day were +0.08, +0.11, and −0.04 mmol/L, respectively, compared with −0.10 mmol/L with placebo. The corresponding p-values were 0.23, 0.18, and 0.72. | 3/4 ModerateEach beta-glucan group had 66 participants, and the placebo group had 65. None of the three comparisons showed a convincing reduction in LDL. This result comes from a 12-week trial of a single tablet formulation. Oat products were studied separately. | 11 publicationSupplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗ | 263 adults with LDL above 3.37 mmol/L, including people who were taking statins and people who were not | - Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗
|
|---|
| Rise in blood glucose after a meal | The total rise in glucose over the post-meal period was 23% lower on average, with a ratio of 0.77 relative to the control (95% confidence interval 0.74–0.81). This was measured as the incremental area under the glucose curve, which captures both the size and duration of the rise. The peak is a separate measure. | 3/4 ModerateThe comparisons covered different meals, doses, and types of beta-glucan, and results varied (I² = 59.9%). Most comparisons involved healthy people, but the overall estimate also includes the other groups listed. The review included 31 studies and 103 comparisons across several outcomes. This result used 98 comparisons. Multiple comparisons from the same study do not count as separate independent studies. The studies measured the response to a single meal. This result does not describe long-term changes in fasting blood sugar or HbA1c. | 22 publications: a meta-analysis and an EFSA scientific opinionThe effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis ↗ | 508 participants across 98 comparisons, including healthy adults and people with overweight, type 2 diabetes, or metabolic syndrome | - The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis ↗
- Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ↗
|
|---|
| Fullness after an oatmeal breakfast | Participants felt fuller over the four hours after eating the oatmeal. The cumulative fullness score over that period was 11,486 versus 9,443 point·min on a 100-point scale (p = 0.001). | 2/4 LowEach participant tried both breakfasts, which helps account for individual differences. However, the oatmeal and breakfast cereal looked noticeably different. The study compared two specific breakfasts. They differed in beta-glucan, sugar, protein, and other properties. The study measured the response to one meal. It did not assess weight loss. Quaker/PepsiCo funded the study, and some authors worked for PepsiCo. | 11 publicationInstant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial ↗ | 48 healthy adults aged 19–63, each of whom tried both breakfasts | - Instant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial ↗
|
|---|
| Food intake at the next lunch | Four hours after eating the oatmeal, participants ate an average of 85 kcal less at lunch than after eating the breakfast cereal (p = 0.012). Drinks were excluded from this estimate. | 2/4 LowFood intake was measured by weighing portions before and after lunch. Each participant tried both breakfasts. The food intake and fullness findings came from the same experiment with 48 participants and count as results from a single study. The 85 kcal reduction applies to one lunch. The study did not measure weight change or subsequent food intake. Quaker/PepsiCo funded the study. | 11 publicationInstant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial ↗ | 48 healthy adults aged 19–63 in the same experiment comparing two breakfasts | - Instant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial ↗
|
|---|
| Tracking a moving target: cognitaven | On day 29, participants tracked a moving target more accurately with a cursor while subtracting numbers aloud. The standardized difference versus placebo was d = 0.54 at 430 mg (p = 0.032) and d = 0.94 at 1,290 mg (p < 0.001). These effect sizes do not represent percentage improvements. | 2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company. | 11 publicationAcute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗ | Healthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis | - Acute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗
|
|---|
| Remembering a sequence of blocks: cognitaven | On day 29, participants performed better on the Corsi block-sequence memory task. Averaged across the three measurements that day, the standardized difference versus placebo was d = 0.64 at 430 mg (p = 0.017) and d = 0.61 at 1,290 mg (p = 0.020). | 2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company. | 11 publicationAcute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗ | Healthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis | - Acute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗
|
|---|
| Other attention tasks: cognitaven | The other tasks showed no consistent benefit over placebo. At 860 mg, accuracy on one attention test (RVIP) was lower 4 hours after the dose on day 29, with d = 0.62 (p < 0.001). No similar decline was seen on the other tests. | 2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company. | 11 publicationAcute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗ | Healthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis | - Acute and Chronic Effects of Green Oat (Avena sativa) Extract on Cognitive Function and Mood during a Laboratory Stressor in Healthy Adults: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Humans ↗
|
|---|
| Attention with long-term Neuravena use | No benefit was detected on tests of attention and concentration. On the primary color-naming test, the mean number of uncorrected errors was 2.2 with the extract and 2.1 with placebo (p = 0.72). The overall attention score also did not differ (p = 1.00). | 2/4 LowIn this small crossover trial, 37 people completed both periods. The article did not describe a separate washout period between them. Testing for a sustained effect took place at least 18 hours after the last dose. The study did not assess effects in the first few hours after dosing. Participants had normal memory and attention at baseline. The authors accounted for multiple comparisons when evaluating many tests. Frutarom funded the study and supplied the capsules. | 11 publicationChronic effects of a wild green oat extract supplementation on cognitive performance in older adults: a randomised, double-blind, placebo-controlled, crossover trial ↗ | 42 healthy people over 60 started the trial, and 37 completed both periods. The mean age was 67 years. | - Chronic effects of a wild green oat extract supplementation on cognitive performance in older adults: a randomised, double-blind, placebo-controlled, crossover trial ↗
|
|---|